Navigation Links
Pharmaceutical Institute Launches New Training Series Focused on Managed Markets Excellence
Date:4/14/2009

RALEIGH, N.C., April 14 /PRNewswire/ -- Pharmaceutical Institute (PI), the leading provider of specialized training solutions for the pharmaceutical and biotech industry, today announced the release of a new e-learning series titled Managed Markets Excellence(TM). The series was developed following a recent benchmarking initiative, including senior training leaders from 17 large and midsize pharmaceutical and biotech companies. The study found that managed markets knowledge emerged as a top-three need, while the need to increase technology to deliver high-quality training, also emerged as a top need.

The Managed Markets Excellence(TM) series, developed in partnership with subject-matter experts from Campbell Alliance, is a comprehensive series of e-courses designed to fill the critical need for basic and advanced managed markets knowledge for commercial professionals.

  • Introduction to Managed Markets - This course provides team members with the managed markets foundation they need to be able to engage in thoughtful discussions about managed care, including proper terminology, the managed markets buying process, the various channels and stakeholders involved in managed markets, the influence of the Pharmacy & Therapeutics (P&T) Committee, how payers and health plans control drug utilization and selection, and the impact of tier placement and generic availability on market share.
  • Reimbursement - The reimbursement environment for pharmaceuticals and healthcare services is extremely complex. This course helps team members understand the various processes and systems used in the industry, including the basic structure for both Medicare and commercial healthcare coverage, coding and billing systems, prospective payment systems, key distinctions in reimbursement systems, and major trends in reimbursement and coverage of specialty drugs.

  • '/>"/>

SOURCE Pharmaceutical Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Researchs 100th Annual Meeting
2. Zenobia Therapeutics Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals
3. Process Analytical Technology (PAT): The Official Language of Pharmaceutical Outsourcing
4. Marinus Pharmaceuticals Raises $20 Million in Series B Financing
5. OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia
6. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
7. Gemin X Pharmaceuticals Selects and Deploys Clinical Force CTMS
8. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
9. VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
10. Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier
11. Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014 OMICS Group’s 5th International ... 18-20 August, 2014 at Double Tree by Hilton Beijing, ... developments in Analytical & Bioanalytical research methods only to ... on this occasion, Dr. Srinubabu Gedela, MD of OMICS ... is a remarkable one in bringing a unique and ...
(Date:7/10/2014)... Russia , July 10, 2014 ... Federation Dmitry Medvedev , presented Russia,s ... company BIOCAD . The Company is developing a ... of MabNext project BIOCAD develops a number of innovative ... and autoimmune diseases. The ceremony took place at the ...
(Date:7/10/2014)... THOUSAND OAKS, Calif., July 10, 2014   Ceres, ... biotechnology and seed company, announced today financial results for ... an update on its business. Ceres reported ... progress in product performance this growing season in Brazil, ... that affected the company,s sorghum evaluation areas for part ...
(Date:7/10/2014)... today in the journal PNAS (Proceedings of the ... of day and sleep deprivation have a significant effect ... looking at the best time of day to test ... for administering medicines effectively. , Researchers from the University ... investigated the links between sleep deprivation, body clock disruption ...
Breaking Biology Technology:A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9Time of day crucial to accurately test for diseases, new research finds 2
... ... ... 2010 -- ProRepro today announced it has become an Autodesk authorized value-added reseller (VAR). ... Southern California. ProRepro’s qualified staff demonstrates in-depth technical and industry knowledge and a commitment ...
... INDIANAPOLIS and WALTHAM, Mass. , May 6, 2010 ... Company (NYSE: LLY ) and Alkermes, Inc. (Nasdaq: ALKS ... classified the BYDUREON™ (exenatide for extended-release injectable suspension) complete response as a ... (PDUFA) action date of October 22, 2010 . , ...
... May 6 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. ( ... company specialized in oncology and endocrinology, today announced that ... Administration (FDA), orphan-drug designation for AEZS-108, its doxorubicin targeted ... is currently in a Phase 2 trial in advanced ...
Cached Biology Technology:ProRepro Becomes a Value-Added Reseller for Autodesk 2BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 2BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 3BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 4BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 5BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 6BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 7BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 8Aeterna Zentaris Receives Orphan-Drug Designation from the FDA for AEZS-108 in Ovarian Cancer 2Aeterna Zentaris Receives Orphan-Drug Designation from the FDA for AEZS-108 in Ovarian Cancer 3
(Date:7/11/2014)... 3, 2014, Shenzhen, China Researchers from Salk Institute ... the first time evaluated the safety and reliability ... successfully developed a new method, TALEN-HDAdV, which could ... stem cell (hiPSC). This study published online in ... theoretical foundation for stem cell-based gene therapy. , ...
(Date:7/11/2014)... researchers, including scientists from the Max Planck Institute for ... major step in understanding photosynthesis, the process by which ... in its atmosphere and which is therefore crucial for ... The researchers report the first direct visualization of a ... in which a specific protein complex, photosystem II, splits ...
(Date:7/11/2014)... Researchers have pioneered a revolutionary new way ... called Virtual Finger, allows scientists to move through ... synapses using the flat surface of their computer ... studies orders of magnitude more efficient, saving time, ... many areas of experimental biology. The software and ...
Breaking Biology News(10 mins):A new genome editing method brings the possibility of gene therapies closer to reality 2A first direct glimpse of photosynthesis in action 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
... shows that while we're winning isolated battles, we could well ... emerald ash borer in eastern Canada and the United States. ... lost timber and ornamental trees, and dramatically change the forest ... more impact than Dutch elm disease. , The soon-to-be published ...
... State University will lead an interdisciplinary team of scientists ... of the most important food crops in Africa, cassava. ... BioCassava Plus project as a recipient of one of ... Created two years ago, the goal of the $450 ...
... environmental challenges , Chemists have discovered details about how the ... heads into the top-most surface of water, an insight ... up environmental hazards. The findings of a team led ... featured on the cover of the Sept. 8 issue of ...
Cached Biology News:Emerald Spectre haunts Ontario's ash forests 2Emerald Spectre haunts Ontario's ash forests 3Research team receives $7.5 million to study cassava 2Scientists discover new way to look at how molecules twist and turn on water 2
Recombinant Mouse LIGHT/TNFSF14...
Viral CMV UL146/vCXC1 Biotinylated Affinity Purified PAb...
Request Info...
D-biotin *50 mM aqueous solution* Secondary Detection Biotin–Avidin Detection Reagents Other...
Biology Products: